ZNF217 and breast cancer: One study determined that ZNF217 mediated collagen matrix abundance-induced AKT activation and mammary epithelial cell proliferation, and triciribine could potentially be utilized as a chemo-preventive agent to decrease the risk of breast cancer for females identified as having enhanced mammographic density [22].